Stay updated on Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial
Sign up to get notified when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.

Latest updates to the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, representing a new publication version of the page. No visible changes to study details or other information are indicated.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now displays recruitment status as 'No longer looking for participants', indicating the study is not enrolling. It also adds helper sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and updates the footer to 'Revision: v3.6.0' while adjusting the 'Intervention/Treatment' heading and removing 'Revision: v3.5.5'.SummaryDifference0.4%

- Check24 days agoChange DetectedThe page has been updated to version v3.5.5 from v3.5.4, representing a small internal update to the page rather than changes to study details.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision tag was added (v3.5.4) and the previous tag (v3.5.3) was removed, indicating a minor update to the study record in the revision history.SummaryDifference0.1%

- Check67 days agoChange DetectedThis update changes the site’s visible revision/version indicator from v3.5.2 to v3.5.3 without altering the trial’s study details.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. There are no user-facing content changes indicated.SummaryDifference0.1%

Stay in the know with updates to Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.